14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

Conatus Pharmaceuticals Inc. Stock Forecast

NASDAQ:CNAT BUY SELL

$0.26 (0%)

Volume: 0

Closed: May 16, 2022

Hollow Logo Score: 0.000

Conatus Pharmaceuticals Inc. Stock Forecast

BUY SELL NASDAQ:CNAT
$0.26 (0%)

Volume: 0

Closed: May 16, 2022

Score Hollow Logo 0.000

CNAT Stock Trend

The stock lies in the middle of a weak rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 4.66% during the next 3 months and, with a 90% probability hold a price between $0.25 and $0.27 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-18 $0.24 $0.25 $0.26
2022-05-19 $0.24 $0.25 $0.26
2022-05-20 $0.24 $0.25 $0.26
2022-05-23 $0.24 $0.25 $0.26
2022-05-24 $0.24 $0.25 $0.26
2022-05-25 $0.24 $0.25 $0.26
2022-05-26 $0.24 $0.25 $0.26
2022-05-27 $0.24 $0.25 $0.26
2022-05-31 $0.24 $0.25 $0.26
2022-06-01 $0.24 $0.25 $0.26
2022-06-02 $0.24 $0.25 $0.26
2022-06-03 $0.24 $0.25 $0.26
2022-06-06 $0.24 $0.25 $0.26
2022-06-07 $0.24 $0.25 $0.26
2022-06-08 $0.24 $0.25 $0.26
2022-06-09 $0.24 $0.25 $0.27
2022-06-10 $0.24 $0.25 $0.27
2022-06-13 $0.24 $0.25 $0.27
2022-06-14 $0.24 $0.25 $0.27
2022-06-15 $0.24 $0.25 $0.27
2022-06-16 $0.24 $0.26 $0.27
2022-06-17 $0.24 $0.26 $0.27
2022-06-21 $0.24 $0.26 $0.27
2022-06-22 $0.24 $0.26 $0.27
2022-06-23 $0.24 $0.26 $0.27
2022-06-24 $0.25 $0.26 $0.27
2022-06-27 $0.25 $0.26 $0.27
2022-06-28 $0.25 $0.26 $0.27
2022-06-29 $0.25 $0.26 $0.27
2022-06-30 $0.25 $0.26 $0.27

About Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its product candidates include Emricasan, an orally active pan-caspase protease inhibitor that is in Phase II clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post-orthotopic liver transplant as a result of hepatitis C virus infection with sust... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT